These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20513005)

  • 41. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carvedilol, metoprolol, and insulin resistance.
    Gonzalez-Feldman E
    JAMA; 2005 Mar; 293(10):1190; author reply 1190. PubMed ID: 15755941
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.
    Fierbinteanu-Braticevici C; Dragomir P; Tribus L; Negreanu L; Bengus A; Usvat R; Andronescu D
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):337-42. PubMed ID: 17205144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Patient with Dilated Cardiomyopathy and Portal Hypertension: Which Beta-Blocker to Use?
    Sarkar R; Paul R; Roy D; Saha A; Sau TJ; Mondal J
    J Assoc Physicians India; 2017 Sep; 65(9):107. PubMed ID: 29313593
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S; Masumura H; Kaifu Y; Yuasa S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Langdon CG; Baxter GA; Young PH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S51-6. PubMed ID: 1721980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of ednit in the treatment of portal hypertension in patients with chronic hepatitis and liver cirrhosis].
    Maev IV; Kaziulin AN; Andreev NG; Aksel'rod AG; Nikushkina IN
    Ter Arkh; 2001; 73(10):79-83. PubMed ID: 11763526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.
    Marchi F; Ciriello G
    Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carvedilol: a new approach to antihypertensive therapy. Proceedings from International Symposium on Carvedilol. Berlin, March 14-17, 1991.
    Clin Investig; 1992; 70 Suppl 1():S1-131. PubMed ID: 1350477
    [No Abstract]   [Full Text] [Related]  

  • 55. Pulmonary complications in cirrhosis.
    Sussman NL; Kochar R; Fallon MB
    Curr Opin Organ Transplant; 2011 Jun; 16(3):281-8. PubMed ID: 21543981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term decreased portal pressure in cirrhotic patients with portal hypertension: reality or dream?].
    Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):246-8. PubMed ID: 19403017
    [No Abstract]   [Full Text] [Related]  

  • 57. Metoprolol in portal hypertension. A controlled study.
    Bützow GH; Remmecke J; Bräuer A
    Klin Wochenschr; 1982 Oct; 60(20):1311-4. PubMed ID: 7144066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis.
    Castaño G; Viudez P; Frider B; Sookoian S
    Gastroenterology; 2002 May; 122(5):1544-5. PubMed ID: 11984541
    [No Abstract]   [Full Text] [Related]  

  • 59. Editorial comment.
    Woo HH
    Urology; 2013 Sep; 82(3):665; discussion 665-6. PubMed ID: 23987162
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of compound Salvia pill combined with propanolol on liver fibrosis and portal hypertension].
    Liang YG; Chu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):382-3. PubMed ID: 12584844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.